Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Opioid-free regimen after neck dissection keeps patients comfortable

Publish date:: November 4, 2019

Key clinical point: A multimodal, opioid-free regimen is effective in patients with thyroid cancer who undergo lateral neck dissections.

Major finding: Before a shift in opioid-prescribing practices, patients went home with a mean 295.4 mean morphine equivalents; after the shift, they received 85.89 MME at discharge (effect size, 1.08).

Study details: Retrospective chart review of 243 patients with thyroid cancer who received lateral neck dissections between 2012 and mid-2019.

Disclosures: Dr. Lim reported no outside sources of funding. He, Dr. Shindo, and a third author reported that they had no conflicts of interest.

Citation:

Lim J et al. ATA 2019, Poster 401.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Head & Neck/Thyroid Cancers

Immunotherapy could fill unmet need in leptomeningeal metastases,

New cancer drugs may have saved more than 1.2 million Americans,

‘Tour de force’ study reveals therapeutic targets in 38% of cancer patients,

Survey quantifies COVID-19’s impact on oncology,

VTE, sepsis risk increased among COVID-19 patients with cancer,